Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Patients With Suboptimal Response Following Nucleos(t)Ide Therapy

NCT04201808 is registered in ClinicalTrials.gov with New Discovery LLC as lead sponsor.

NCT NCT04201808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04201808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Patients With Suboptimal Response Following Nucleos(t)Ide Therapy
Lead sponsor
New Discovery LLC
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2021
Completion date
September 30, 2023
Enrollment
100 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, chronic